MET and neoplasm: While, in the adenocarcinoma patient population, independent of other clinicopathological variables, a high cytoplasmic MET expression was a significant negative prognosticator, as determined by IHC, a similar correlation was not found in patients with MET gene copy number gain, i.e. the absolute MET gene copy number in tumor cells did not affect the prognosis.